Tickers

1. Composite Trajectory Verdict

For a capital-intensive, foreign-currency-exposed education operator, the income statement and cash flow statement carry the most weight because they reveal whether core pricing and enrollment momentum translates into discretionary cash after heavy campus investment.

Composite Trajectory: Improving

Revenue grew 9% in FY 2025 to $1,701.9M after 6% growth in FY 2024 (10-K 2025-12-31, Consolidated Statements of Operations). Operating income accelerated to 15% growth ($431.1M) from 10% in FY 2024 (10-K 2025-12-31, Consolidated Statements of Operations). Adjusted EBITDA (non-GAAP) rose 15% to $518.9M (10-K 2025-12-31, MD&A). Operating cash flow surged 57% to $366.2M in FY 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The balance sheet shows higher cash ($146.7M vs $91.4M) and equity ($1,187.4M vs $957.1M) but also rising lease and debt obligations (10-K 2025-12-31, Consolidated Balance Sheets). The sole drag is a 5% decline in GAAP net income attributable to Laureate ($281.6M vs $296.5M) caused by a $85M foreign-currency swing (10-K 2025-12-31, MD&A).

2. Red Flags

• GAAP net income fell 5% YoY while operating income rose 15% — the divergence stems from a $34.6M foreign-currency loss in FY 2025 versus a $50.7M gain in FY 2024, an $85.3M swing tied to intercompany loans (10-K 2025-12-31, MD&A; 10-K 2025-12-31, Consolidated Statements of Operations).
• Capital expenditures jumped 43% to $103.0M in FY 2025 (10-K 2025-12-31, MD&A; 10-K 2025-12-31, Consolidated Statements of Cash Flows), outpacing the 57% rise in operating cash flow and absorbing most incremental cash generation.
• Stock repurchases accelerated to $215.2M in FY 2025 from $102.1M in FY 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows), funded partly by drawing on subsidiary credit lines (aggregate lines-of-credit balances rose to $43.3M from $30.0M) (10-K 2025-12-31, Note 8).
• Total lease liabilities (operating + finance) increased 20% to $517.2M ($387.8M operating + $129.1M finance) from $429.3M at end-FY 2024 (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 9).
• Goodwill and tradenames represent 36% of total assets ($803.5M / $2,206.4M) with no impairment recorded but ongoing FX translation volatility (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 7).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Revenue increased 9% to $1,701.9M in FY 2025 (vs 6% in FY 2024), driven by 9% organic constant-currency growth in Mexico and 7% in Peru (10-K 2025-12-31, MD&A). Operating income rose 15% to $431.1M (vs 10% in FY 2024), with both segments expanding margins: Mexico Adjusted EBITDA margin improved to 26.1% from 24.5%, Peru to 39.9% from 39.1% (10-K 2025-12-31, MD&A segment tables). Consolidated Adjusted EBITDA (non-GAAP) grew 15% to $518.9M (10-K 2025-12-31, MD&A). GAAP net income attributable to Laureate declined 5% to $281.6M solely due to the foreign-currency swing noted above; income from continuing operations before tax fell only 3% to $400.9M (10-K 2025-12-31, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash from operating activities jumped 57% to $366.2M in FY 2025 from $232.7M in FY 2024, reflecting higher operating income, $31.4M less cash tax paid, and $7.6M less cash interest (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-K 2025-12-31, MD&A). Capital expenditures rose 43% to $103.0M (10-K 2025-12-31, Consolidated Statements of Cash Flows), yielding free cash flow (operating minus capex) of approximately $263M, up from ~$161M in FY 2024. Financing outflows increased to $222.5M driven by $215.2M of share repurchases (10-K 2025-12-31, Consolidated Statements of Cash Flows). Cash and restricted cash ended FY 2025 at $152.1M, up 55% from $97.9M (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Cash and equivalents rose 61% to $146.7M; total equity increased 24% to $1,187.4M (10-K 2025-12-31, Consolidated Balance Sheets). However, total liabilities grew 13% to $1,017.6M. Senior and other debt plus finance leases climbed 26% to $129.1M (10-K 2025-12-31, Note 8). Operating lease liabilities rose 19% to $387.8M with $98.8M of minimum payments due in 2026 (10-K 2025-12-31, Note 9). Accounts receivable net grew 47% to $134.7M while allowance for doubtful accounts increased 24% to $125.1M (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 2). The net debt plus lease liability position ($517.2M) exceeds cash by 3.4x, though interest coverage (operating income / interest expense) improved to ~40x from ~21x (10-K 2025-12-31, Consolidated Statements of Operations).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet figures for Q1–Q2 2026 and Q2–Q3 2025 — the provided 10-Qs contain only truncated MD&A sections without financial statements.
• Year-over-year quarterly comparisons (e.g., Q2 2026 vs Q2 2025) to assess intra-year momentum and seasonality.
• Segment-level quarterly revenue, Adjusted EBITDA, and enrollment trends for Mexico and Peru.
• Detailed breakdown of the $17.7M decline in investing proceeds from asset sales in FY 2025 (referenced but not itemized in the 10-K MD&A).